These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32448751)

  • 1. Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis.
    Pluchino S; Smith JA; Peruzzotti-Jametti L
    Trends Mol Med; 2020 Oct; 26(10):898-912. PubMed ID: 32448751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Mitochondrial Metabolism in Neuroinflammation: Towards a Therapy for Progressive Multiple Sclerosis.
    Peruzzotti-Jametti L; Pluchino S
    Trends Mol Med; 2018 Oct; 24(10):838-855. PubMed ID: 30100517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cell Therapies for Progressive Multiple Sclerosis.
    Smith JA; Nicaise AM; Ionescu RB; Hamel R; Peruzzotti-Jametti L; Pluchino S
    Front Cell Dev Biol; 2021; 9():696434. PubMed ID: 34307372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based therapeutic strategies for multiple sclerosis.
    Scolding NJ; Pasquini M; Reingold SC; Cohen JA; ; ;
    Brain; 2017 Nov; 140(11):2776-2796. PubMed ID: 29053779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells.
    Zhang C; Cao J; Li X; Xu H; Wang W; Wang L; Zhao X; Li W; Jiao J; Hu B; Zhou Q; Zhao T
    Sci China Life Sci; 2016 Sep; 59(9):950-7. PubMed ID: 27233903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis.
    Volpe G; Bernstock JD; Peruzzotti-Jametti L; Pluchino S
    J Neuroimmunol; 2019 Jun; 331():11-27. PubMed ID: 28034466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
    Obradović D; Tukić L; Radovinović-Tasić S; Petrović B; Elez M; Ostojić G; Balint B
    Vojnosanit Pregl; 2016 May; 73(5):504-8. PubMed ID: 27430119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-Derived Extracellular Succinate Licenses Neural Stem Cells to Suppress Chronic Neuroinflammation.
    Peruzzotti-Jametti L; Bernstock JD; Vicario N; Costa ASH; Kwok CK; Leonardi T; Booty LM; Bicci I; Balzarotti B; Volpe G; Mallucci G; Manferrari G; Donegà M; Iraci N; Braga A; Hallenbeck JM; Murphy MP; Edenhofer F; Frezza C; Pluchino S
    Cell Stem Cell; 2018 Mar; 22(3):355-368.e13. PubMed ID: 29478844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain pathology of a patient 7years after autologous hematopoietic stem cell transplantation for multiple sclerosis.
    Wundes A; Bowen JD; Kraft GH; Maravilla KR; McLaughlin B; von Geldern G; Georges G; Nash RA; Lu JQ
    J Neurol Sci; 2017 Feb; 373():339-341. PubMed ID: 28131217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis.
    Liang J; Zhang H; Hua B; Wang H; Wang J; Han Z; Sun L
    Mult Scler; 2009 May; 15(5):644-6. PubMed ID: 19389752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repair what is lost: Neuroprotection through neural stem cells in progressive MS.
    Schoonheim MM; Strijbis EMM
    Cell Rep Med; 2023 Mar; 4(3):100985. PubMed ID: 36948155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New therapeutic approaches in progressive multiple sclerosis].
    Faissner S; Gold R
    Fortschr Neurol Psychiatr; 2019 Nov; 87(11):653-671. PubMed ID: 31783427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neural stem-cell treatment for progressive multiple sclerosis.
    Fossati V; Peruzzotti-Jametti L; Pluchino S
    Nat Med; 2023 Jan; 29(1):27-28. PubMed ID: 36639562
    [No Abstract]   [Full Text] [Related]  

  • 14. Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
    Casanova B; Jarque I; Gascón F; Hernández-Boluda JC; Pérez-Miralles F; de la Rubia J; Alcalá C; Sanz J; Mallada J; Cervelló A; Navarré A; Carcelén-Gadea M; Boscá I; Gil-Perotin S; Solano C; Sanz MA; Coret F
    Neurol Sci; 2017 Jul; 38(7):1213-1221. PubMed ID: 28396953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells promote remyelination in the murine experimental autoimmune encephalomyelitis model of multiple sclerosis following human neural stem cell transplant.
    McIntyre LL; Greilach SA; Othy S; Sears-Kraxberger I; Wi B; Ayala-Angulo J; Vu E; Pham Q; Silva J; Dang K; Rezk F; Steward O; Cahalan MD; Lane TE; Walsh CM
    Neurobiol Dis; 2020 Jul; 140():104868. PubMed ID: 32276110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neural stem cell secretome and its role in brain repair.
    Willis CM; Nicaise AM; Peruzzotti-Jametti L; Pluchino S
    Brain Res; 2020 Feb; 1729():146615. PubMed ID: 31863730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores.
    Burt RK; Cohen BA; Russell E; Spero K; Joshi A; Oyama Y; Karpus WJ; Luo K; Jovanovic B; Traynor A; Karlin K; Stefoski D; Burns WH
    Blood; 2003 Oct; 102(7):2373-8. PubMed ID: 12842989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial.
    Mancardi GL; Sormani MP; Gualandi F; Saiz A; Carreras E; Merelli E; Donelli A; Lugaresi A; Di Bartolomeo P; Rottoli MR; Rambaldi A; Amato MP; Massacesi L; Di Gioia M; Vuolo L; Currò D; Roccatagliata L; Filippi M; Aguglia U; Iacopino P; Farge D; Saccardi R; ;
    Neurology; 2015 Mar; 84(10):981-8. PubMed ID: 25672923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials.
    Giusto E; Donegà M; Cossetti C; Pluchino S
    Exp Neurol; 2014 Oct; 260():19-32. PubMed ID: 23507035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function.
    Ontaneda D; Thompson AJ; Fox RJ; Cohen JA
    Lancet; 2017 Apr; 389(10076):1357-1366. PubMed ID: 27889191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.